AAAAAA

   
Results: 1-15 |
Results: 15
A vaccination strategy incorporating DNA priming and mucosal boosting using tetanus toxin fragment C (TetC)
Authors: Stratford, R Douce, G Bowe, F Dougan, G
Citation: R. Stratford et al., A vaccination strategy incorporating DNA priming and mucosal boosting using tetanus toxin fragment C (TetC), VACCINE, 20(3-4), 2001, pp. 516-525
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants
Authors: Pizza, M Giuliani, MM Fontana, MR Monaci, E Douce, G Dougan, G Mills, KHG Rappuoli, R Del Giudice, G
Citation: M. Pizza et al., Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants, VACCINE, 19(17-19), 2001, pp. 2534-2541
LTK63 and LTR72, two mucosal adjuvants ready for clinical trials
Authors: Pizza, M Giuliani, MM Fontana, MR Douce, G Dougan, G Rappuoli, R
Citation: M. Pizza et al., LTK63 and LTR72, two mucosal adjuvants ready for clinical trials, INT J MED M, 290(4-5), 2000, pp. 455-461
Transmission of IgA and IgG monoclonal antibodies to mucosal fluids following intranasal or parenteral delivery
Authors: Falero-Diaz, G Challacombe, S Rahman, D Mistry, M Douce, G Dougan, G Acosta, A Ivanyi, J
Citation: G. Falero-diaz et al., Transmission of IgA and IgG monoclonal antibodies to mucosal fluids following intranasal or parenteral delivery, INT A AL IM, 122(2), 2000, pp. 143-150
The immune responses to bacterial antigens encountered in vivo at mucosal surfaces
Authors: Dougan, G Ghaem-Maghami, M Pickard, D Frankel, G Douce, G Clare, S Dunstan, S Simmons, C
Citation: G. Dougan et al., The immune responses to bacterial antigens encountered in vivo at mucosal surfaces, PHI T ROY B, 355(1397), 2000, pp. 705-712
Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus
Authors: Stratford, R Douce, G Zhang-Barber, L Fairweather, N Eskola, J Dougan, G
Citation: R. Stratford et al., Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus, VACCINE, 19(7-8), 2000, pp. 810-815
Intranasal vaccination of mice against infection with Mycobacterium tuberculosis
Authors: Falero-Diaz, G Challacombe, S Banerjee, D Douce, G Boyd, A Ivanyi, J
Citation: G. Falero-diaz et al., Intranasal vaccination of mice against infection with Mycobacterium tuberculosis, VACCINE, 18(28), 2000, pp. 3223-3229
Salmonella enterica serovar Typhimurium surA mutants are attenuated and effective live oral vaccines
Authors: Sydenham, M Douce, G Bowe, F Ahmed, S Chatfield, S Dougan, G
Citation: M. Sydenham et al., Salmonella enterica serovar Typhimurium surA mutants are attenuated and effective live oral vaccines, INFEC IMMUN, 68(3), 2000, pp. 1109-1115
Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins
Authors: Rappuoli, R Pizza, M Douce, G Dougan, G
Citation: R. Rappuoli et al., Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins, IMMUNOL TOD, 20(11), 1999, pp. 493-500
Laryngeal aspergillosis following high dose inhaled fluticasone therapy for asthma
Authors: Fairfax, AJ David, V Douce, G
Citation: Aj. Fairfax et al., Laryngeal aspergillosis following high dose inhaled fluticasone therapy for asthma, THORAX, 54(9), 1999, pp. 860-861
Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants
Authors: Douce, G Giannelli, V Pizza, M Lewis, D Everest, P Rappuoli, R Dougan, G
Citation: G. Douce et al., Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants, INFEC IMMUN, 67(9), 1999, pp. 4400-4406
Evaluation of Salmonella typhimurium mutants in a model of experimental gastroenteritis
Authors: Everest, P Ketley, J Hardy, S Douce, G Khan, S Shea, J Holden, D Maskell, D Dougan, G
Citation: P. Everest et al., Evaluation of Salmonella typhimurium mutants in a model of experimental gastroenteritis, INFEC IMMUN, 67(6), 1999, pp. 2815-2821
Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease
Authors: Higgins, LM Frankel, G Douce, G Dougan, G MacDonald, TT
Citation: Lm. Higgins et al., Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease, INFEC IMMUN, 67(6), 1999, pp. 3031-3039
Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A
Authors: Ward, SJ Douce, G Figueiredo, D Dougan, G Wren, BW
Citation: Sj. Ward et al., Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A, INFEC IMMUN, 67(5), 1999, pp. 2145-2152
Local and systemic neutralizing antibody responses induced by intranasal immunization with the nontoxic binding domain of toxin a from Clostridium difficile
Authors: Ward, SJ Douce, G Dougan, G Wren, BW
Citation: Sj. Ward et al., Local and systemic neutralizing antibody responses induced by intranasal immunization with the nontoxic binding domain of toxin a from Clostridium difficile, INFEC IMMUN, 67(10), 1999, pp. 5124-5132
Risultati: 1-15 |